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Abstract
Background: This study investigated the psychometric properties of the 9-Item Shared Decision-
Making Questionnaire (SDM-Q-9) and the 9-Item Shared Decision-Making Questionnaire–
Physician version (SDM-Q-Doc) using comprehensive and thorough psychometric methods in 
an oncology setting. 
Methods: Cancer survivors (n = 1783; 928 [52.05%] males) and physicians (n=154; 121 
[78.58%] males) participated in this study. Each cancer survivor completed the SDM-Q-9. 
Physicians completed the SDM-Q-Doc for each of their cancer patient. Confirmatory factor 
analysis (CFA) and Rasch model were used to test the psychometric properties of SDM-Q-9 and 
SDM-Q-Doc. 
Results: SDM-Q-9 and SDM-Q-Doc demonstrated unidimensional structure in CFA and Rasch 
model. In addition, the measurement invariance was supported for both SDM-Q-9 and SDM-Q-
Doc across sex using the multigroup CFA. Rash analysis indicates no differential item functioning 
(DIF)across sex for all the SDM-Q-9 and SDM-Q-Doc items. SDM-Q-9 and SDM-Q-Doc were 
moderately correlated (r = 0.41; P < 0.001). 
Conclusion: SDM-Q-9 and SDM-Q-Doc are valid instruments to assess shared decision making 
in the oncology setting.
Article History:
Received: 15 Dec. 2018
Accepted: 12 Jan. 2019
ePublished: 25 May 2019
 
Keywords:
Confirmatory factor analysis, 
Cancer, Rasch, Instrumental 
study
*Corresponding Authors:
Chung-Ying Lin, PhD, 
Tel: 852-2766-6755; Fax: 
852-2330-8656, Email: 
cylin36933@gmail.com; 
Amir H. Pakpour; 
Phone: +98 28 33239259; 
Fax: +98 28 33239259; 
Emails: pakpour_amir@yahoo.
com, apakpour@qums.ac.ir
ARTICLE INFO
Citation: Nejati B, Lin CC, Imani V, Browall M, Lin CY, Broström A, et al. Validating patient and physician versions of the shared decision 
making questionnaire in oncology setting. Health Promot Perspect. 2019;9(2):105-114. doi: 10.15171/hpp.2019.15.
Original Article
Introduction 
Cancer is one of the most important causes of death and 
human health issues during the past decades.1 According 
to the World Health Organization (WHO) report, cancer 
accounted for near 9.6 million deaths in 2018 globally.2 The 
most common cancer types include lung, breast, prostate, 
and gastrointestinal tract cancers. With the development 
of advanced diagnostic tools and the progress made in 
various cancer treatments, the survival rates of cancer 
patients have kept increasing. In addition to the medical 
parts, efforts have been made to improve the quality of 
their physical and psychosocial support during the past 
few years.1 However, many of the cancer survivors still 
experience several unmet needs, including education, 
information, communication and provider relationship.3
In order to achieve the quality of cancer care, healthcare 
providers should have good communication with cancer 
survivors. Indeed, it is claimed that the optimal decision 
for a patient can be made using the model of shared 
decision making; that is, at least a clinician and a patient 
share information to each other. Clinicians offer treatment 
options with potential risks and benefits; patients express 
preferences and values.4 Through shared decision 
making, active participation in the decision-making 
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process is increased with the following benefits: improved 
knowledge for patient, decreased decision conflict 
between clinicians and patients, and facilitated decision 
reaching.5 Additionally, less anxiety and better treatment 
outcomes have been proposed to those patients who used 
shared decision making.6 The benefits of shared decision 
making are also been proposed for cancer survivors that 
oncological decisions made by shared decision making 
can enrich the treatment process for patients to gain 
benefits from curative cancer treatments.7
Thus, the 9-item Shared Decision Making 
Questionnaire (SDM-Q-9) and the Shared Decision 
Making Questionnaire-physician version (SDM-Q-Doc) 
have been developed recently.8-10 Both measures were 
found to be feasible and effective in interventions.11 
However, psychometric properties of both SDM-Q-9 
and SDM-Q-Doc need additional investigation because 
of the following reasons. Specifically, to the best of our 
knowledge, only two studies have validated the SDM-Q-9 
using a sample of breast cancer patients or a sample 
majority consisted of colon, breast, and stomach cancer 
patients.12,13 Another study has validated the SDM-Q-Doc 
using a sample of medical oncologists who rated SDM-Q-
Doc for their oncology patients with majority diagnoses 
were colon cancer (40.4%) and breast cancer (35.2%).7 
Thus, psychometric evidence of SDM-Q-9 and SDM-Q-
Doc is understudied in the oncology setting. For example, 
we are unsure whether SDM-Q-9 is sound and valid for 
cancer survivors other than the aforementioned cancers; 
we have no information whether SDM-Q-Doc is reliable 
and can be applied to cancer survivors when the physician 
raters are not oncologists. Given that the scientific nature 
is to accumulate evidence using different methods,14 
especially that the psychometric properties are highly 
depended on the studied samples,15 further psychometric 
evaluation for SDM-Q-9 and SDM-Q-Doc is thus crucial. 
Specifically, SDM-Q-9 should be tested among different 
types of cancer diagnoses and SDM-Q-Doc should be 
examined among various areas of physician expertise. 
In addition, to our knowledge, both SDM-Q-9 and SDM-
Q-Doc have not been investigated for their measurement 
invariance and differential item functioning (DIF) across 
sex. Given that males and females usually have different 
thoughts and diverse interpretations in item descriptions,16 
it is essential for healthcare professionals to understand 
whether male and female cancer survivors interpret the 
SDM-Q-9 items similarly; whether male and female 
physicians interpret the SDM-Q-Doc items similarly. After 
ensuring that the measures are measurement invariant and 
have no DIF items across sex, healthcare professionals can 
conclude that males and females report the same thing in 
their shared decision making using SDM-Q-9 and SDM-
Q-Doc. In other words, we need not to worry about the 
gender bias when using either SDM-Q-9 or SDM-Q-Doc. 
The purpose of this study was to investigate the 
psychometric properties of SDM-Q-9 and SDM-Q-
Doc using comprehensive and thorough psychometric 
methods in an oncology setting. 
Materials and Methods
Participants and recruitment process
The sample of this methodological study was recruited 
from five teaching hospitals in cities of Tehran, Tabriz, 
Qazvin and Karaj from November 2017 to July 2018. 
Participants included cancer survivors and physicians. 
Patients were included in this study if they met the 
following criteria: (1) 18 years or more, (2) confirmed 
diagnosis of cancer by pathological examination, and 
(3) the ability to communicate in Persian, and providing 
informed consent. Exclusion criteria were: (1) severe 
cognitive impairment as suggested by mini mental 
state examination (MMSE) score; i.e., less than 21, (2) 
with visual impairment, and (3) with major psychiatric 
disorders (as diagnosed by a psychiatrist). 
The patients were informed the study by their treating 
physicians (i.e., the gynecologist, oncologist, and urologist 
who agreed to participate in this study) and each physician 
invited 12 of their outpatients after giving the consultation. 
However, the patients were well informed and ensured that 
there will be no changes in their treatment if they reject to 
participate. If a patient agreed to participate in this study 
and signed a written informed consent, the patient, his/her 
physician, and one of his/her family member completed 
questionnaires described in the Measures section. 
Translation procedure for SDM-Q-9 and SDM-Q-Doc
Given that SDM-Q-9 and SDM-Q-Doc are paralleled 
instruments completed by different parties (i.e., patients 
and physicians), we considered that translating both 
instruments simultaneously could tackle the characteristics 
of the paralleled instruments. Several steps were taken to 
translate both measures (i.e., SDM-Q-9 and SDM-Q-Doc) 
from English to Persian based on international guidelines 
on cross-cultural adoption of self-report measures.17-19 In 
the first stage, two bilingual translators who were native 
Persian speakers independently translated both SDM-Q-9 
and SDM-Q-Doc from English to Persian. In the next step, 
the translators and a recording observer compared the two 
translations. Any discrepancies between the translations 
were identified and resolved to synthesize as an interim 
Persian version. In the third stage, the synthesized Persian 
measures were translated back into English by two bilingual 
translators who were blinded to the English versions. An 
expert committee (including oncologist, psychiatrist, 
methodologist, nurse, psychologist, psychometrist and the 
translators) was convened to consolidate all the translated 
versions of the questionnaires and meanwhile tackle 
cultural adaptation. Necessary changes were made after 
reviewing all documents to achieve linguistic equivalence 
between the Persian and English versions. The pre-final 
Persian versions were then piloted on patients (mean 
age = 57.6 years, 23 males and 24 females) and physicians 
(mean age = 35.2 years, 14 males and 10 females) to make 
sure that the Persian versions were equivalent to their 
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English correspondences in clinical setting. The final 
Persian SDM-Q-9 was administrated on 1783 cancer 
patients and Persian SDM-Q-Doc on 154 physicians. 
Measures
The physician completed SDM-Q-Doc and a questionnaire 
on physician satisfaction for that patient. One family 
member nominated by the patient (e.g., spouse, parent, 
child, or sibling) completed the Family Decision-Making 
Self-Efficacy Scale. A research assistant contacted the 
patient to complete a series of questionnaires (please see 
the followings for detailed information) and background 
information sheet.
9-Item Shared Decision-Making Questionnaire (SDM-Q-9)
The SDM-Q-9 consists of 9 items and evaluates how a 
patient perceives his or her involvement in the shared 
decision making during the medication consultation.9 
All the items were rated on a 6-point Likert scale from 
0 (completely disagree) to 5 (completely agree), where 
a higher score indicates higher involvement of a patient 
in decision making. The single-factor structure of 
the SDM-Q-9 has been verified in both confirmatory 
factor analysis (CFA) and Rasch model.12,20 The internal 
consistency of the SDM-Q-9 in this current study was 
0.919.
9-Item Shared Decision-Making Questionnaire–Physician 
version (SDM-Q-Doc)
The SDM-Q-Doc has parallel nine items to the SDM-Q-9 
with different subject terms in each item (the subject 
term is my doctor in SDM-Q-9 and I in SDM-Q-Doc). 
All the items were rated on a 6-point Likert scale from 
0 (completely disagree) to 5 (completely agree), where 
a higher score indicates higher involvement of a patient 
in decision making.10 The single-factor structure of the 
SDM-Q-9 has been verified in the CFA,21 and the SDM-Q-
Doc has its linguistic validity established in Persian.18 The 
internal consistency of the SDM-Q-Doc in this current 
study was 0.820.
Hospital Anxiety and Depression Scale (HADS)
The HADS consists of 14 items assessing depression (7 
items) and anxiety (7 items). All the items were rated 
on a four-point Likert scale from 0 to 3, where a higher 
score indicates more depression or anxiety. Moreover, 
the Persian version of the HADS has been validated in 
a sample with epilepsy.22 The internal consistency of the 
depression and anxiety domains in this current study were 
0.83 and 0.88.
Family Decision-Making Self-Efficacy Scale (FDMSE)
The FDMSE consists two 13-item scenarios to assess 
family self-efficacy in decision making.23 Sample items 
in the two scenarios are “If my loved one prefers to have 
help in making health care decisions, I am confident that 
I will be able to help make decisions about his/her health 
care (Conscious scenario).” and “If my loved one becomes 
too ill to make health care decisions, I am confident that 
I will be able to make decisions about his/her health care 
(Unconscious scenario)”. Because we were interested in 
the process of making the decision by patients and all our 
participants had capacity in decision making, we only used 
the conscious scenario and did not use the unconscious 
scenario. Given that there is no Persian version of the 
FDMSE, we translated the FDMSE into Persian using 
standard procedure to ensure its linguistic validity. The 
internal consistency of the FDMSE in this current study 
was 0.82.
Patient Self-Advocacy Scale (PSAS)
The PSAS consists of 12 items assessing illness education 
(4 items), assertiveness (4 items), and mindful non-
adherence (4 items). All the items were rated on a 5-point 
Likert scale from 1 to 5, where a higher score indicates 
better illness literacy, higher confidence in taking care 
of illness, and paying more attention to non-adherence. 
Moreover, the Persian version of the PSAS has been 
validated in a sample with chronic illness.24 The internal 
consistency of the PSAS in this current study was 0.85.
Insomnia Severity Index (ISI)
The ISI consists of 7 items assessing the severity of sleep 
problem with all items rated on a 5-point Likert scale from 
0 to 4, where a higher score indicates severe insomnia. 
Moreover, the Persian version of the ISI has been validated 
in a sample with sleep problems.25 The internal consistency 
of the ISI in this current study was 0.89.
Epworth Sleepiness Scale (ESS)
The ESS consists of 8 items assessing the severity of 
daytime sleepiness with all items rated on a 4-point Likert 
scale from 0 to 3, where a higher score indicates greater 
sleepiness. Moreover, the Persian version of the ESS has 
been validated in Iranian children and adolescents.26 The 
internal consistency of the ESS in this current study was 
0.82.
Physician satisfaction
Four items were designed in this study to examine the 
physician satisfaction. The four items asked to what 
extent the physician is satisfied with (1) the information 
provided about the disease; (2) the risk of recurrence; (3) 
the side effects of treatment; and (4) the time dedicated 
to informing the patient. All items were rated from 0 to 8, 
with a higher score indicates the higher level of physicians’ 
satisfaction with the provided information. The internal 
consistency of the four items in this current study was 
0.88.
7-item Short Assessment of Patient Satisfaction (SAPS)
The SAPS consists of 7 items assessing the patient 
satisfaction with all items rated on a 5-point Likert scale 
from 0 to 4, where a higher score indicates higher level of 
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satisfaction.27 Given that there is no Persian version of the 
SAPS, we translated the SAPS into Persian using standard 
procedure to ensure its linguistic validity. The internal 
consistency of the SAPS in this current study was 0.80.
Data analysis
Two series of psychometric testing were conducted with 
one using classical test theory and another using Rasch 
analysis. The classical test theory analyses were done 
using IBM SPSS 23.0 (IBM Corp., Armonk, NY) or Mplus 
(version 7.4; Los Angeles, CA); Rasch analyses were done 
using Winstep 4.1.0 software (winsteps.com, Beaverton, 
OR).
For the testing using classical test theory, we used 
CFA, internal consistency using Cronbach’s α, corrected 
item-total correlation, test-retest reliability using Pearson 
correlation, acceptance (i.e., the completion rate for each 
item), ceiling and floor effects (i.e., how many percentages 
of the participants have the lowest or highest score in 
each instrument), and standard error of measurement. 
Moreover, both SDM-Q-9 and SDM-Q-Doc were tested 
as having a single-factor structure each in the CFA, and 
the CFA results were used to report factor loadings, 
average variance extracted, and composite reliability. 
Several cutoffs were then used to determine the acceptable 
properties. For CFA, a nonsignificant χ2 test, a comparative 
fit index (CFI) >0.9, a Tucker-Lewis index (TLI) >0.9, a root 
mean square error of approximation (RMSEA) <0.08, and 
a standardized root mean square residual (SRMR) <0.08 
support the single-factor structure for SDM-Q-9 or SDM-
Q-Doc.28 For internal consistency, Cronbach’s α is expected 
to be higher than 0.729; for corrected item-total correlation 
and test-retest reliability, values are expected to be higher 
than 0.4.28 A higher acceptance and a lower standard error 
of measurement indicate better psychometric properties.29 
Moreover, factor loading higher than 0.4; average variance 
extracted higher than 0.5, and composite reliability higher 
than 0.6 are in anticipation.29 
Three nested CFA models were additionally used to test 
the measurement invariance of both instruments (viz., 
SDM-Q-9 and SDM-Q-Doc) across males and females. 
The three models were (1) a configural model that treats 
SDM-Q-9 and SDM-Q-Doc as a single-factor structure, 
(2) a model that constrains males and females having 
equal factor loadings in the single-factor structure, and (3) 
a model that constrains males and females having equal 
factor loadings and equal item intercepts in the single-
factor structure. A χ2 difference test, ∆CFI, ∆SRMR, and 
∆RMSEA were used to examine whether measurement 
invariance is supported. If the χ2 difference test is 
nonsignificant, the measurement invariance is supported. 
If the χ2 difference test is significant, we expected to have 
∆CFI, ∆SRMR, and ∆RMSEA all less than 0.01 to support 
the measurement invariance.30 
For the testing using Rasch analysis, each item was 
examined whether it contributes sufficiently and 
appropriately to the underlying single-factor in shared 
decision making. Specifically, both infit mean square 
(MnSq) and outfit MnSQ range between 0.5 and 1.5 are 
expected, where a value <0.5 indicates the redundancy of 
an item and a value >1.5 indicates the inappropriateness 
of an item.29 In addition, difficulty of each item was 
calculated using the Rasch model with an additive unit 
(viz., logit). Given the nature of sample-free in Rasch (i.e., 
the psychometric results derived from the Rasch are not 
influenced by the sample characteristics), item separation 
reliability, person separation reliability, item separation 
index, and person separation index were demonstrated. 
The acceptable value for separation reliability was higher 
than 0.7; for separation index was higher than 2.31 DIF was 
then computed to examine whether males and females 
interpret the item description similarly and a DIF contrast 
(i.e., item difficulty for females- item difficulty for males) 
>0.5 indicates substantial DIF.32
After ensuring the psychometric properties of both 
SDM-Q-9 and SDM-Q-Doc, we investigated the Pearson 
correlations between the two instruments. Then, Pearson 
correlation was applied again between SDM-Q-9 and 
the relevant and external criteria as follows, depression, 
anxiety, family decision making self-efficacy, illness 
education, assertiveness, mindful non-adherence, 
insomnia, sleepiness, physician satisfaction, and patient 
satisfaction. Pearson correlation was applied again 
between SDM-Q-Doc and the followings, depression, 
anxiety, insomnia, sleepiness, physician satisfaction, and 
patient satisfaction.
Results
Participants’ characteristics
The M (SD) age of the 1783 cancer survivors was 58.63 
(12.83) years, and slightly more than half of them were 
males (n = 928; 52.05%). In average, their educational 
years was 6.03 (2.96), time since diagnosis was 2.87 (1.66) 
years, MMSE score was 25.12 (1.90), and Karnofsky 
Performance Scale Score was 70.68 (12.81). More than half 
of the cancer survivors were currently married (n = 1198; 
67.19%). Regarding their diagnosis, the highest three were 
gastrointestinal cancer (n = 582; 32.64%), breast cancer 
(n = 284; 15.92%), and skin cancer (n = 264; 14.81%). In 
terms of the characteristics of 154 physicians, their mean 
age was 38.69 (10.34) years with more than three quarters 
were males (n = 121; 78.58%). In average, they have been 
employed as a physician for 9.62 (5.81) years. Additionally, 
most of them were gynecologist (n = 63; 40.91%), followed 
by oncologist (n = 34; 22.08%), and urologist (n = 57; 
37.01%; Table 1).
Psychometric properties of the SDM-Q-9
The SDM-Q-9 was found to have promising psychometric 
properties in both item and scale levels. In the item level, 
acceptances were high (96.7% to 99.3%); factor loadings 
derived from CFA were satisfactory (0.77 to 0.94); 
corrected item-total correlations were strong (0.62 to 0.77); 
test-retest reliability calculated using Pearson correlation 
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was excellent (0.70 to 0.93); infit (0.85 to 1.23) and outfit 
MnSq (0.83 to 1.12) derived from Rasch analysis were fit; 
and no substantial DIF (DIF contrast = -0.22 to 0.28) was 
found across sex (Table 2). 
In the scale level tested using classical test theory, 
the SDM-Q-9 had low ceiling (2.13%) and floor 
effects (3.87%); high internal consistency (α = 0.919); 
satisfactory fit indices except for significant χ2 test in 
CFA (CFI = 0.971, TLI = 0.944, RMSEA = 0.070, and 
SRMR = 0.050); acceptable average variance extracted 
(0.70) and composite reliability (0.95); low standard error 
of measurement (2.89); acceptable test-retest reliability 
(r = 0.85; Table 3); supported measurement invariance 
(nonsignificant χ2 tests between the nested models; Table 
4). The Rasch analysis also supported the promising 
psychometric properties of the SDM-Q-9 in scale level: 
separation reliability (0.84 and 0.92) and separation 
indices (3.47 and 2.28) were adequate (Table 3).
Psychometric properties of the SDM-Q-Doc
The SDM-Q-Doc was found to have promising 
psychometric properties in both item and scale levels. In 
the item level, acceptances were high (97.3% to 99.3%); 
factor loadings derived from CFA were satisfactory (0.60 
to 0.88); corrected item-total correlations were strong 
(0.41 to 0.73); test-retest reliability calculated using 
Table 1. Characteristics of the participants (n = 1783 for patients; n = 154 for 
physicians)
Patient
Age (y), M (SD) 58.63 (12.83)
Sex (male), No. (%) 928 (52.05%)
Educational year, M (SD) 6.03 (2.96)
Marital status, No. (%) 
  Single 286 (16.04%)
  Married 1198 (67.19%)
  Widowed/divorced 299 (16.77%)
Mini-mental state exam, M (SD) 25.12 (1.90)
Karnofsky Performance Scale Score, M (SD) 70.68 (12.81)
Diagnosis, No. (%)
  Gastrointestinal cancer 582 (32.64%)
  Breast cancer 284 (15.92%)
  Multiple myeloma 193 (10.82%)
  Skin cancer 264 (14.81%)
  Lung cancer 212 (11.89%)
  Genitourinary cancer 150 (8.41%)
  Others 98 (5.50%)
Time since diagnosis in years, M (SD) 2.87 (1.66)
Physicians
Age (years), M (SD) 38.69 (10.34)
Sex (Male), No. (%) 121 (78.58%)
Number of years employed; M (SD) 9.62 (5.81)
Profession, No. (%)
  Gynecologist 63 (40.91%)
  Oncologist 34 (22.08%)
  Urologist 57 (37.01%)
Pearson correlation was excellent (0.70 to 0.86); infit 
(0.80 to 1.16) and outfit MnSq (0.85 to 1.15) derived 
from Rasch analysis were fit; and no substantial DIF (DIF 
contrast = -0.39 to 0.43) was found across sex (Table 2). 
In the scale level tested using classical test theory, 
the SDM-Q-9 had low ceiling (5.19%) and floor 
effects (7.80%); high internal consistency (α = 0.820); 
satisfactory fit indices except for significant χ2 test in 
CFA (CFI = 0.968, TLI = 0.939, RMSEA = 0.078, and 
SRMR = 0.052); acceptable average variance extracted 
(0.52) and composite reliability (0.91); low standard error 
of measurement (2.64); acceptable test-retest reliability 
(r = 0.81; Table 3); supported measurement invariance 
(nonsignificant χ2 tests between the nested models; Table 
4). The Rasch analysis also supported the promising 
psychometric properties of the SDM-Q-9 in scale level: 
separation reliability (0.79 and 0.84) and separation 
indices (2.31 and 2.92) were adequate (Table 3).
Correlations between SDM-Q-9, SDM-Q-Doc, and 
external criteria
A moderate and positive correlation between SDM-Q-9 
and SDM-Q-Doc (r = 0.41; P < 0.001) was found (Table 
5). Additionally, the SDM-Q-Doc was significantly 
correlated with depression (r = -0.60; P < 0.001), anxiety 
(r = -0.66; P < 0.001), family decision-making self-efficacy 
(r = 0.52; P < 0.001), illness education (r = 0.53; P < 0.001), 
assertiveness (r = 0.62; P < 0.001), mindful non-adherence 
(r = 0.40; P < 0.001), insomnia (r = -0.58; P < 0.001), 
sleepiness (r = -0.60; P < 0.001), physician satisfaction 
(r = 0.41; P < 0.001), and patient satisfaction (r = 0.69; 
P < 0.001). The SDM-Q-9 was significantly correlated 
with depression (r = -0.55; P < 0.001), anxiety (r = -0.62; 
P < 0.001), insomnia (r = -0.49; P < 0.001), sleepiness 
(r = -0.53; P < 0.001), physician satisfaction (r = 0.67), and 
patient satisfaction (r = 0.33; P < 0.001). 
Discussion
This study, to the best of our knowledge, is the first to 
examine the measurement invariance and DIF across sex 
for both SDM-Q-9 and SDM-Q-Doc in different diagnoses 
of cancer survivors, including gastrointestinal cancer, 
breast cancer, multiple myeloma, skin cancer, lung cancer, 
and genitourinary cancer. In addition, comprehensive and 
thorough evidence in their psychometric properties was 
examined. Specifically, the unidimensionality was verified 
by our findings from CFA and Rasch models for both 
SDM-Q-9 and SDM-Q-Doc. Our DIF and measurement 
invariance findings further suggested that male cancer 
survivors did not have different interpretation in the 
SDM-Q-9 items from female cancer survivors; the male 
physicians did not interpret the SDM-Q-Doc items 
differently from female physicians. Moreover, both 
SDM-Q-9 and SDM-Q-Doc were moderately correlated to 
relevant external criteria listed in our Table 5. Therefore, 
we tentatively concluded that both SDM-Q-9 and SDM-
Q-Doc can be feasibly used for healthcare professionals 
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Table 2. Psychometric properties of the 9-Item Shared Decision-Making Questionnaire (SDM-Q-9) and Shared Decision-Making Questionnaire–Physician version (SDM-Q-Doc) in item level
Analyses from classical test theory Analyses from Rasch
Acceptance (completion 
rates in %) Factor loading
a Item-total correlation Test-retest reliabilityb Infit MnSq Outfit MnSq Difficulty DIF contrast across gendercd
Item SDM-Q-9 SDM-Q-Doc SDM-Q-9 SDM-Q-Doc SDM-Q-9 SDM-Q-Doc SDM-Q-9 SDM-Q-Doc SDM-Q-9 SDM-Q-Doc SDM-Q-9 SDM-Q-Doc SDM-Q-9 SDM-Q-Doc SDM-Q-9 SDM-Q-Doc
1 98.2 99.1 0.83 0.65 0.62 0.49 0.78 0.73 1.23 0.98 1.12 1.06 -0.16 -0.37 -0.08 0.43
2 97.3 97.3 0.82 0.69 0.70 0.53 0.93 0.82 1.01 0.82 1.09 0.85 -0.14 -0.14 -0.03 0.18
3 99.3 98.6 0.84 0.64 0.69 0.41 0.88 0.80 0.93 0.95 1.08 0.88 0.13 -0.72 -0.06 -0.39
4 96.7 99.3 0.84 0.60 0.73 0.54 0.73 0.74 1.02 0.98 0.89 0.98 -0.40 -0.31 0.01 0.17
5 96.9 98.7 0.88 0.76 0.77 0.50 0.70 0.76 0.85 1.02 0.83 0.99 -0.27 -0.14 0.28 0.03
6 99.3 97.4 0.82 0.67 0.72 0.54 0.75 0.70 0.96 1.16 0.98 1.15 0.33 0.45 -0.22 -0.08
7 98.6 99.1 0.78 0.88 0.73 0.69 0.88 0.78 0.93 0.80 1.09 0.85 0.42 0.59 -0.05 -0.18
8 98.4 99.3 0.94 0.85 0.75 0.73 0.72 0.77 0.99 0.91 0.96 0.96 0.28 0.65 0.12 0.16
9 97.3 99.3 0.77 0.69 0.73 0.46 0.86 0.86 0.97 1.10 0.91 1.12 -0.18 0.11 0.10 -0.02
Abbreviations: MnSq, mean square error; DIF, differential item functioning.
a Based on the first-order confirmatory factor analysis. 
b Using Pearson correlation. 
c DIF contrast >0.5 indicates substantial DIF. 
d DIF contrast across gender = Difficulty for females-Difficulty for males.
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to assess the degree of shared decision making among 
different types of cancer survivors. 
As we compared our findings to previous studies on 
cancer survivors,7,12,13 slightly differences were found. Wu 
et al12 found that item 1 in the SDM-Q-9 was misfit for the 
breast cancer survivors, and they recommended removing 
this item from SDM-Q-9. In contrast, our findings 
indicate that item 1 fit in the SDM-Q-9; however, item 1 
as compared with other items did perform worse in the 
unidimensionality. Specifically, both infit and outfit MnSq 
of item 1 were the highest among the MnSq of other items. 
That is, item 1 was deviated from the underlying concept 
of shared decision making in the SDM-Q-9; however, 
the deviation is strong and unacceptable in the findings 
from Wu et al12 but is weak and acceptable in our findings. 
Additionally, Calderon et al13 like Wu et al12 found that 
item 1 may jeopardize the unidimensional structure in the 
SDM-Q-9. Calderon et al13 found that the SDM-Q-9 could 
have one-factor structure if removing item 1; contrarily, 
the SDM-Q-9 fit better to a two-factor structure if item 
1 retained in the questionnaire. A possible reason is 
the different samples: we recruited a sample with more 
heterogeneous diagnoses in cancers than did Wu et al12 
and Calderon et al13 Given that our sample was more 
diverse than the samples of Wu et al12 and Calderon et al,13 
we would recommend retaining item 1 in the SDM-Q-9. 
Nevertheless, the psychometric evidence of SDM-Q-9 
is still insufficient, and future studies are warranted to 
Table 3. Psychometric properties of the 9-Item Shared Decision-Making Questionnaire (SDM-Q-9) and Shared Decision-Making Questionnaire–Physician 
version (SDM-Q-Doc) in scale level
Psychometric testing SDM-Q-9 SDM-Q-Doc Suggested cutoff
Ceiling effects (%) 2.13 5.19 <20
Floor effects (%) 3.87 7.80 <20
Internal consistency (Cronbach’s α) 0.919 0.820 >0.7
Confirmatory factor analysis
  χ2 (df) 78.60 (27)* 33.58 (27) * Non-significant
  Comparative fit index 0.971 0.968 >0.9
  Tucker-Lewis index 0.944 0.939 >0.9
  Root-mean square error of approximation 0.070 0.078 <0.08
  Standardized root mean square residual 0.050 0.052 <0.08
Average Variance Extracted 0.70 0.52 >0.5
Composite Reliability 0.95 0.91 >0.6
Standard error of measurement 2.89 2.64 The smaller the better
Item separation reliability from Rasch 0.92 0.84 >0.7
Item separation index from Rasch 3.47 2.31 >2
Person separation reliability from Rasch 0.84 0.79 >0.7
Person separation index from Rasch 2.28 2.92 >2
Test-retest reliability by Pearson correlation 0.85 0.81 >0.4
*P < 0.001.
Table 4. Measurement invariance across gender on the 9-Item Shared Decision-Making Questionnaire (SDM-Q-9) and Shared Decision-Making 
Questionnaire–Physician version (SDM-Q-Doc) through confirmatory factor analysis
Model and comparisons 
Fit indices
χ2 (df) ∆χ2 (∆df) CFI ∆CFI SRMR ∆SRMR RMSEA ∆RMSEA
SDM-Q-9
M1: Configural 133.35 (54)* 0.969 0.048 0.063
M2: Plus all loadings constrained 147.61 (63)* 0.973 0.045 0.060
M3: Plus all intercepts constrained 159.93 (72)* 0.978 0.043 0.058
M2−M1 14.26 (9) 0.004 -0.003 -0.003
M3−M2 12.32 (9) 0.005 -0.001 -0.002
SDM-Q-Doc
M1: Configural 153.21 (54)* 0.965 0.051 0.065
M2: Plus all loadings constrained 167.36 (63)* 0.970 0.048 0.061
M3: Plus all intercepts constraineda 181.19 (72)* 0.973 0.046 0.059
M2−M1 14.15 (9) -0.005 -0.003 -0.004
M3−M2 13.83 (9) 0.003 -0.002 -0.002
Abbreviations: CFI, comparative fit index; SRMR, standardized root mean square residual; RMSEA, root mean square error of approximation.
* P < 0.05
a M1 = Model 1, a configural model; M2 = Model 2, a model based on M1 with all factor loadings constrained being equal across groups; M3 = Mode 3, a 
model based on M2 with all item intercepts constrained being equal across groups.
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examine whether item 1 should be retained. 
Calderon et al7 recently studied the psychometric 
properties of the SDM-Q-Doc, and they found that the 
SDM-Q-Doc was significantly correlated to physician 
satisfactory. Our findings also demonstrated similar 
correlation between SDM-Q-Doc and physician 
satisfactory. However, the factorial structure of SDM-Q-
Doc was found to be different between the findings of 
Calderon et al7 and those of ours. Specifically, Calderon et 
al7 used exploratory factor analysis and CFA to conclude 
a two-factor structure for the SDM-Q-Doc. In contrast, 
we used CFA and Rasch model to conclude a single-
factor structure for the SDM-Q-Doc. We suspected that 
the number of recruited physicians could be a reason 
to cause such a difference. Calderon et al7 recruited 32 
oncologists and we recruited a total of 154 physicians 
across three fields of expertise (gynecologist, oncologist, 
and urologist). Although the 32 oncologists in the study 
of Calderon et al7 rated the SDM-Q-Doc on 520 cancer 
survivors with different diagnoses, we can say that the 
two-factor structure of SDM-Q-Doc was solely based on 
the perspective of the 32 oncologists. On the other hand, 
the number of physicians in our study was much larger 
than that of Calderon et al7 Thus, the representativeness 
of our participants should be stronger than that of the 
participants in Calderon et al7 However, future studies are 
warranted to confirm the factorial structure of SDM-Q-
Doc because to the best our knowledge, only Calderon et 
al7 and we have examined the factorial structure for SDM-
Q-Doc on cancer patients.
In addition to the three studies on cancer patients,7,12,13 
our psychometric results were in line with the studies 
on populations other than cancer patients. In the 
SDM-Q-9, Scholl et al33 found that it has high internal 
consistency (α = 0.92) with satisfactory corrected item-
total correlations (0.52 to 0.85) among patients with type 
2 diabetes, chronic pain, and depression. De las Cuevas et 
al,34 also found satisfactory internal consistency (α = 0.89) 
Table 5. Correlations between the 9-Item Shared Decision-Making 
Questionnaire (SDM-Q-9), Shared Decision-Making Questionnaire–
Physician version (SDM-Q-Doc), and external criteria
SDM-Q-Doc SDM-Q-9
SDM-Q-9 0.41 -
SDM-Q-Doc - 0.41
Depressiona -0.60 -0.55
Anxietya -0.66 -0.62
Family Decision-Making Self-Efficacy Scale 0.52 -
Illness educationb 0.53 -
Assertivenessb 0.62 -
Mindful non-adherenceb 0.40 -
Insomnia Severity Index -0.58 -0.49
Epworth Sleepiness Scale -0.60 -0.53
Physician satisfaction 0.41 0.67
Patient satisfactionc 0.69 0.33
a Measured using Hospital Anxiety and Depression Scale.
b Measured using Patient Self-Advocacy Scale. 
c Measured using the 7-item Short Assessment of Patient Satisfaction. 
All P values < 0.001.
in the SDM-Q-9; they further concluded that the 
SDM-Q-9 has a unidimensional structure after removing 
item. In the SDM-Q-Doc, Simon et al35 like our results 
demonstrate the unidimensional structure derived from 
Rasch analysis.
Strength and limitations
The study has the following strengths. First, a standard and 
robust translation process was applied to both SDM-Q-9 
and SDM-Q-Doc to tackle their cultural adaptation, 
linguistic validity, and paralleled characteristics. Second, 
the sample in our study was heterogeneous and large. 
For cancer survivors, we recruited 1783 patients with 
different cancer diagnoses. For physicians, we recruited 
154 experts in different fields of expertise. Therefore, 
the representativeness of our sample should be strong. 
Third, we applied comprehensive and thorough testing in 
psychometrics to examine both SDM-Q-9 and SDM-Q-
Doc. With all the psychometric findings were satisfactory, 
the use of SDM-Q-9 and SDM-Q-Doc is highly 
recommended in clinical practice. 
There are some limitations in this study. First, although 
our sample is large and heterogeneous, all the participants 
were recruited in Iran. Therefore, the use of SDM-Q-9 and 
SDM-Q-Doc is restricted for Iranian. Second, following by 
the first limitation, our findings cannot be generalized to 
cancer survivors who are in severe condition. Specifically, 
we only recruited those with apparently good cognitive 
ability and had no serious psychiatric disorders. Therefore, 
we were unsure whether the SDM-Q-9 and SDM-Q-Doc 
can be used for cancer survivors with sever condition. 
However, given that patients should provide their opinions 
in the model of shared decision making, we believe that 
this limitation should not be serious. Third, the SDM-
Q-Doc was completed by physicians for their patients. 
Therefore, each physician rated about 12 SDM-Q-Doc and 
it is possible that the SDM-Q-Doc questionnaires rated by 
the same physician had dependency. However, we did not 
tackle this into our psychometric testing because we have 
checked the dependencies using intraclass correlation 
coefficient. Because the intraclass correlation coefficient 
was low (0.04), we decided not to use multilevel analysis 
to fulfill the parsimony principle in psychometric testing. 
Conclusion 
This study validated the SDM-Q-9 for use among various 
types of cancer survivors and the SDM-Q-Doc for use 
among physicians with different areas of expertise on their 
cancer patients. Given the increasing number of cancer 
survivors and the importance of shared decision making 
in oncology setting, using both measures to evaluate 
the level of shared decision making can help healthcare 
professionals provide personalized care efficiently ana 
subsequently improved the treatment outcomes. 
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